Skip to main content
SpringerLink
Log in

Cabergoline

Disease progression following the development of secondary drug resistance in macroprolactinoma: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Laboy-Ortiz IE, et al. Secondary Resistance to dopamine agonist after thirteen months of successful treatment in a 42 years old man. Boletin de la Asociacion Medica de Puerto Rico 108: 31-36, No. 1, 2016 - Puerto Rico

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cabergoline. Reactions Weekly 1696, 76 (2018). https://doi.org/10.1007/s40278-018-44264-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44264-7

Search

Navigation